Drugs / Compound-X
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05663879 Comparator | Dec 2022 → Jul 2023 | — | IlDong Pharmaceutical Co Ltd | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Compound-X | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05663879 ↗ |